DE2212285C3 - Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen - Google Patents

Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen

Info

Publication number
DE2212285C3
DE2212285C3 DE2212285A DE2212285A DE2212285C3 DE 2212285 C3 DE2212285 C3 DE 2212285C3 DE 2212285 A DE2212285 A DE 2212285A DE 2212285 A DE2212285 A DE 2212285A DE 2212285 C3 DE2212285 C3 DE 2212285C3
Authority
DE
Germany
Prior art keywords
activity
solution
enzyme
ribonuclease
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2212285A
Other languages
German (de)
English (en)
Other versions
DE2212285A1 (de
DE2212285B2 (de
Inventor
Brian Robert Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2212285A1 publication Critical patent/DE2212285A1/de
Publication of DE2212285B2 publication Critical patent/DE2212285B2/de
Application granted granted Critical
Publication of DE2212285C3 publication Critical patent/DE2212285C3/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/575—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
DE2212285A 1971-03-16 1972-03-14 Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen Expired DE2212285C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB696371A GB1389662A (en) 1971-03-16 1971-03-16 Biological test

Publications (3)

Publication Number Publication Date
DE2212285A1 DE2212285A1 (de) 1972-10-26
DE2212285B2 DE2212285B2 (de) 1980-05-22
DE2212285C3 true DE2212285C3 (de) 1981-02-12

Family

ID=9824046

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2212285A Expired DE2212285C3 (de) 1971-03-16 1972-03-14 Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen

Country Status (12)

Country Link
US (1) US3816263A (Direct)
JP (1) JPS5432357B1 (Direct)
AT (1) AT334325B (Direct)
BE (1) BE780592A (Direct)
CA (1) CA969457A (Direct)
CH (1) CH587916A5 (Direct)
DE (1) DE2212285C3 (Direct)
FR (1) FR2129656A5 (Direct)
GB (1) GB1389662A (Direct)
NL (1) NL176792C (Direct)
SE (1) SE406646B (Direct)
ZA (1) ZA721457B (Direct)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988115A (en) * 1975-09-18 1976-10-26 Modabber Farrokh Z Diagnostic method for determining pathological condition by antigen-combining capacity of lymphocytes
US4072574A (en) * 1976-07-30 1978-02-07 The Institute For Cancer Research System for in vitro assay for mutagenicity and/or carcinogenicity of chemicals or other exogenous agents
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4345026A (en) * 1981-01-12 1982-08-17 The Children's Hospital Medical Center Mutagenicity assay
US5413915A (en) * 1988-07-12 1995-05-09 Resource Technologies Group, Inc. Method and sensor for detecting toxic chemical exposure effects and metabolic activation of carcinogenic chemical agents
FR2681327B1 (fr) * 1991-09-16 1993-12-24 Institut Nal Sante Recherc Medic Proteines capables notamment de constituer des facteurs de regulation fonctionnelle de la cellule et leurs applications biologiques.
US6773885B1 (en) * 2000-09-29 2004-08-10 Integrated Dna Technologies, Inc. Compositions and methods for visual ribonuclease detection assays

Also Published As

Publication number Publication date
AT334325B (de) 1976-01-10
NL176792B (nl) 1985-01-02
NL7203383A (Direct) 1972-09-19
CA969457A (en) 1975-06-17
DE2212285A1 (de) 1972-10-26
NL176792C (nl) 1985-06-03
CH587916A5 (Direct) 1977-05-13
BE780592A (fr) 1972-09-13
DE2212285B2 (de) 1980-05-22
FR2129656A5 (Direct) 1972-10-27
GB1389662A (en) 1975-04-03
US3816263A (en) 1974-06-11
ZA721457B (en) 1972-11-29
ATA213572A (de) 1976-05-15
SE406646B (sv) 1979-02-19
JPS5432357B1 (Direct) 1979-10-13

Similar Documents

Publication Publication Date Title
DE3017152C2 (Direct)
EP0088420B1 (de) Verfahren zur spezifischen Bestimmung des Cholesterins der LDL-Fraktion im Serum
DE3249743C2 (Direct)
EP0250991B1 (de) Verfahren zur spezifischen Bestimmung des Serumfructosamingehalts sowie hierfür geeignetes Reagenzgemisch
DE2724758B2 (Direct)
DE1189763B (de) Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens
DE2128670B2 (de) Immunologische isoenzym-bestimmungsmethode
DE2212285C3 (de) Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen
DE1273226B (de) Diagnostisches Mittel zum Nachweis von Keton-Koerpern in Koerperfluessigkeiten und Herstellungsverfahren des Mittels
DE2653537A1 (de) Verfahren und mittel zur bestimmung von hydroperoxiden
DE2101796A1 (de) Verfahren zur Bestimmung von Tnglycenden im Blutserum
EP0009596A1 (de) Wässrige Lipid-Standardlösung
EP0141922B1 (de) Verfahren zur Verringerung einer Trübung in Kontrollseren
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE2558536C3 (Direct)
EP0105443B1 (de) Verfahren zur selektiven Herstellung reduzierter Sauerstoffspezies und hierfür geeignete Reagentien
WO1984002720A1 (fr) Procede et reactif pour l'analyse differentielle des isoenzymes de la phosphatase alcaline
DE112013002316T5 (de) Systeme und Verfahren für Assays von im nicht-nüchternen Zustand gewonnenem LDL-Cholesterin
DE3138602C2 (Direct)
EP0020895A1 (de) Partielles Thromboplastin
DE4306278C2 (de) Verfahren zur quantitativen Analyse von 1,5-Anhydroglucitol
DE4242794A1 (en) Quantitative automated determn. of 1,5-anhydro:glucitol - using pyranose oxidase from Basidiomycetes fungi no.52
DE2804356C2 (de) Verfahren zur Hydrolyse von proteingebundenen Cholesterinestern
EP0428137B1 (de) Verfahren zur Erhöhung der enzymatischen Reaktivität von Beta-Galactosidase
DE3221579A1 (de) Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee